EA201391743A1 - Фармацевтическая композиция, содержащая дротаверин - Google Patents

Фармацевтическая композиция, содержащая дротаверин

Info

Publication number
EA201391743A1
EA201391743A1 EA201391743A EA201391743A EA201391743A1 EA 201391743 A1 EA201391743 A1 EA 201391743A1 EA 201391743 A EA201391743 A EA 201391743A EA 201391743 A EA201391743 A EA 201391743A EA 201391743 A1 EA201391743 A1 EA 201391743A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
drotaverin
composition containing
composition
relates
Prior art date
Application number
EA201391743A
Other languages
English (en)
Other versions
EA022944B1 (ru
Inventor
Судхакара Рао Бадабхагни
Нилеш Джайсваль
Правин Кхуллар
Кум Прасад
Original Assignee
Хиноин Прайвит Ко Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хиноин Прайвит Ко Лтд. filed Critical Хиноин Прайвит Ко Лтд.
Publication of EA201391743A1 publication Critical patent/EA201391743A1/ru
Publication of EA022944B1 publication Critical patent/EA022944B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Настоящее изобретение относится к фармацевтической композиции дротаверина гидрохлорида в системе растворителя, пригодной в качестве жидкой композиции наполнения. В другом аспекте настоящее изобретение также относится к способу получения указанной фармацевтической композиции и к применению указанной композиции для получения лекарственного средства, предназначенного для лечения спазмов и острых болей.
EA201391743A 2011-05-20 2012-05-16 Фармацевтическая композиция, содержащая дротаверин EA022944B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1728CH2011 2011-05-20
US201161499850P 2011-06-22 2011-06-22
EP11305922 2011-07-13
PCT/EP2012/059163 WO2012159964A1 (en) 2011-05-20 2012-05-16 Pharmaceutical composition comprising drotaverine

Publications (2)

Publication Number Publication Date
EA201391743A1 true EA201391743A1 (ru) 2014-03-31
EA022944B1 EA022944B1 (ru) 2016-03-31

Family

ID=47216628

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201391743A EA022944B1 (ru) 2011-05-20 2012-05-16 Фармацевтическая композиция, содержащая дротаверин

Country Status (10)

Country Link
US (1) US20140080864A1 (ru)
EP (1) EP2709599B1 (ru)
AR (1) AR086448A1 (ru)
BR (1) BR112013029621A2 (ru)
EA (1) EA022944B1 (ru)
HU (1) HUE038538T2 (ru)
MX (1) MX354485B (ru)
PL (1) PL2709599T3 (ru)
UY (1) UY34081A (ru)
WO (1) WO2012159964A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115279346A (zh) 2020-03-09 2022-11-01 苏什玛·保罗·伯利亚 包含屈他维林或其盐的控制释放制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197207B (en) * 1985-12-04 1989-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient
HUT60926A (en) * 1991-04-12 1992-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition suitable for reducing or preventing increased thrombocyte-aggregation capability
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents

Also Published As

Publication number Publication date
EA022944B1 (ru) 2016-03-31
WO2012159964A1 (en) 2012-11-29
MX2013013574A (es) 2014-09-22
MX354485B (es) 2018-03-07
US20140080864A1 (en) 2014-03-20
BR112013029621A2 (pt) 2016-12-13
EP2709599A1 (en) 2014-03-26
EP2709599B1 (en) 2017-12-20
AR086448A1 (es) 2013-12-11
HUE038538T2 (hu) 2018-10-29
PL2709599T3 (pl) 2018-07-31
UY34081A (es) 2013-01-03

Similar Documents

Publication Publication Date Title
EA201591166A1 (ru) Ингибиторы аутотаксина
EA201270722A1 (ru) Формы рифаксимина и их применение
EA201500207A1 (ru) Гетероароматические соединения в качестве ингибиторов втк
EA201692506A2 (ru) Ингибиторы репликации вирусов гриппа
EA201600191A8 (ru) Фармацевтические композиции, содержащие диастереомеры макролида, способы их синтезирования и терапевтическое применение
EA201590053A1 (ru) Модуляторы пути системы комплемента и их применение
AR093377A1 (es) Anticuerpos anti-notch y conjugados de anticuerpo-farmaco
EA201590520A1 (ru) Фармацевтическая композиция с покрытием, содержащая регорафениб
EA201492216A1 (ru) Ингибиторы бромодомена и их применение
EA201270720A1 (ru) Модуляторы рецептора андрогенов и их применение
BR112014021103A8 (pt) anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
UA115231C2 (uk) Сполуки імідазопіролідинонів
CL2013000063A1 (es) Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion.
UA112288C2 (uk) Склад антитіла, що специфічно зв'язує рецептор а іl-17, і терапевтичні режими
GB201118656D0 (en) New compounds
MX2014002731A (es) Forma polimorfica de clorhidrato de pridopidina.
EA201790032A1 (ru) Бициклически замещённые урацилы и их применение
EA201290859A1 (ru) Лечение люпус-артрита с использованием лаквинимода
EA201590667A1 (ru) Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
EP2701700A4 (en) PHARMACEUTICAL THERAPY FOR INHIBITING CHEMOTHERAPY-INDUCED SIDE EFFECTS AND CORRESPONDING PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING METHOD AND KITS
EA201400002A1 (ru) Способы лечения заболеваний сетчатки
EA201391171A1 (ru) Формы рифаксимина и их применение
UA113627C2 (xx) Кристалічна форма циклоспорину a, фармацевтична композиція та спосіб лікування

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KZ

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU